The buyer question
Is mushroom coffee actually worth it — and which brand?
By Brewlune · Updated November 2, 2026
For study types, participant counts and the limits of dose comparisons, read our health benefits of mushroom coffee: per-mushroom evidence table.
Honestly: it depends what you are buying it for, and anyone who answers with a flat yes is selling you something. There are no large clinical trials of mushroom coffee blends — none. What exists is early human research on individual mushrooms, mostly small studies, and a much larger pile of marketing that rounds those studies up to certainty.
That is why the practical question is not “does mushroom coffee work” but “can I check what is in this bag.” Per-species dosing — the milligrams of each individual mushroom printed on the label, rather than one number for a blended powder — is the one claim a buyer can verify at the shelf without trusting anyone. Most of the category does not print it. Brewlune does, on the front of every bag.
Compare lion’s mane research doses with Brewlune’s recipe amounts before treating an ingredient study as a product claim.
What does the research actually say?
Less than the category implies. The most-cited human trial on lion's mane — Mori et al., 2009, in Phytotherapy Research — was double-blind and placebo-controlled, enrolled about 30 adults with mild cognitive impairment, and found improved cognitive scores while participants took the extract, with the effect fading after they stopped. That is a real result, and it is also one small trial on one mushroom, not evidence for any coffee blend. No mushroom coffee blend has been tested in a clinical trial.
The literature also carries the unflattering entries. Kikuchi et al., 2014, in Clinical Nephrology documented oxalate kidney damage after years of daily raw chaga powder at grams-per-day doses. Dose and preparation are the whole question there, and we wrote up what that case does and does not mean in our chaga field note — because an evidence-first pitch only means something if it survives the evidence that cuts against it.
Why don't most brands print their doses?
Because a “proprietary blend” lets a label carry six impressive species names without disclosing that some may be present in token amounts — and because powders made from mycelium grown on grain are partly grain by weight, which a per-species figure would expose. Printing the milligrams of each mushroom removes the room to round up. It is a small typographic decision with a large consequence: it converts a marketing claim into a checkable one.
How do you verify a dosage claim?
(If coffee itself is what you are avoiding, the same checks apply to mushroom matcha.) Three checks, in order. First, the front of the bag: does it state milligrams per individual species, or one number for a blend? Brewlune's figures are printed per species — see Brewlune's per-species dosage breakdown for every blend's numbers. Second, the extract type: fruiting body or mycelium on grain — the fruiting body is the part most published research examines. Third, whether anyone checks the numbers at all: that is what Brewlune's third-party lab testing program exists to document, batch by batch.
